Acyclovir and Cabergoline drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Acyclovir (acyclovir) and Cabergoline (cabergoline). Common drug interactions include blood calcium increased among females and back pain among males.

The phase IV clinical study analyzes what interactions people have when they take Acyclovir and Cabergoline. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Acyclovir?

Acyclovir has active ingredients of acyclovir. It is often used in herpes simplex. eHealthMe is studying from 54,961 Acyclovir users. Check the latest studies of Acyclovir.

What is Cabergoline?

Cabergoline has active ingredients of cabergoline. It is often used in prolactinoma. eHealthMe is studying from 6,257 Cabergoline users. Check the latest studies of Cabergoline.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 31, 2026

23 people who take Acyclovir and Cabergoline together, and have interactions are studied.

Acyclovir and Cabergoline drug interactions.

What are the common drug interactions of Acyclovir and Cabergoline, by gender? *:

female:

  1. Blood calcium increased
  2. Blood parathyroid hormone increased
  3. Blood pressure increased
  4. Blood prolactin increased
  5. Cardiac disorder
  6. Cervical polyp (tumour on the surface of the cervical canal)
  7. Constipation
  8. Cough
  9. Diarrhoea
  10. Dyspnoea (difficult or laboured respiration)

male:

  1. Back pain
  2. Memory impairment
  3. Pyrexia (fever)

What are the common drug interactions of Acyclovir and Cabergoline, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Renal failure chronic (long lasting kidney dysfunction)
  2. Neutropenia (an abnormally low number of neutrophils)

50-59:

  1. Back pain

60+:

  1. Femur fracture
  2. Fall
  3. General physical health deterioration (weak health status)
  4. Malignant neoplasm progression (cancer tumour came back)
  5. Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
  6. Memory impairment
  7. Subarachnoid haemorrhage (blood leaks into the space between two membranes that surround the brain)
  8. Surgery

What are the existing conditions these people have? *

  1. Prolactin-Producing Pituitary Tumor: 10 people, 43.48%
  2. Hyperprolactinaemia (abnormally high levels of prolactin in the blood): 10 people, 43.48%
  3. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 10 people, 43.48%
  4. High Blood Pressure: 9 people, 39.13%
  5. Delirium (wild excitement): 9 people, 39.13%
  6. Multiple Myeloma (cancer of the plasma cells): 7 people, 30.43%
  7. Cushing's Syndrome (obesity, a rounded face, increased fat): 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Acyclovir and Cabergoline?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Acyclovir and Cabergoline:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Acyclovir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cabergoline:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Acyclovir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cabergoline and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on acyclovir and cabergoline (the active ingredients of Acyclovir and Cabergoline, respectively), and Acyclovir and Cabergoline (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: